ArticleTranslational cancer research2026

A case report of hemophagocytic lymphohistiocytosis secondary to tislelizumab and bevacizumab combination therapy for renal cell carcinoma.

Linli Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.